US Map / Virginia
State VA

Clinical Trials in Virginia

Virginia is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Virginia and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 276 actively recruiting studies with Virginia sites out of 276 registered in total. The busiest research areas in Virginia are Breast Cancer, Advanced Solid Tumor, Colorectal Cancer. Leading sponsors running trials in the state include Virginia Commonwealth University, University of Virginia, National Cancer Institute (NCI). By stage, Virginia trials break down as Phase 1 (75), Phase 2 (82), Phase 3 (85), Phase 4 (13).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
276
Recruiting Now
276
← Back to US Map
Top Conditions in Virginia
Breast Cancer (12)Advanced Solid Tumor (9)Colorectal Cancer (8)Solid Tumor (8)Prostate Cancer (8)Advanced Solid Tumors (7)Solid Tumors (6)Cancer (5)Ovarian Cancer (5)Obesity (5)Endometrial Cancer (4)Non-Small Cell Lung Cancer (4)

Frequently Asked Questions — Clinical Trials in Virginia

How many clinical trials are currently recruiting in Virginia?
ClinicalMetric currently tracks 276 actively recruiting clinical trials with at least one location in Virginia. The total number of registered studies—including active but not currently enrolling trials—is 276. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Virginia?
Virginia hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Advanced Solid Tumor, Colorectal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Virginia serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Virginia?
To join a clinical trial in Virginia, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Virginia maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Virginia

NCT07181681 Phase 1
Recruiting
A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeut...
Condition
Solid Tumors
Enrollment
63 pts
Location
United States, Australia, China
Sponsor
BeOne Medicines
View Trial →
NCT07221500 Phase 2
Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyr...
Condition
Chronic Lymphocytic Leukemia (CLL)
Enrollment
100 pts
Location
United States, France, Italy
Sponsor
Nurix Therapeutics, Inc.
View Trial →
NCT06966700 Phase 3
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Br...
Condition
Breast Neoplasms
Enrollment
2,400 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06423911 Phase 3
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
Condition
Chronic Myeloid Leukemia
Enrollment
333 pts
Location
United States, Australia, Belgium
Sponsor
Ascentage Pharma Group Inc.
View Trial →
NCT06911632 N/A
Recruiting
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring ...
Condition
Pulmonary Hypertension
Enrollment
900 pts
Location
United States
Sponsor
Tempus AI
View Trial →
NCT06861309 N/A
Recruiting
Placental Imaging Techniques
Condition
Fetal Growth Restriction (FGR)
Enrollment
60 pts
Location
United States
Sponsor
Carilion Clinic
View Trial →
NCT06059963 N/A
Recruiting
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
Condition
Colorectal Cancer
Enrollment
12,000 pts
Location
United States
Sponsor
Universal Diagnostics
View Trial →
NCT06585410 Phase 3
Recruiting
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous S...
Condition
Cutaneous Squamous Cell Carcinoma (CSCC)
Enrollment
369 pts
Location
United States, Australia
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT04763356 N/A
Recruiting
Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy
Condition
Chemotherapy-induced Peripheral Neuropathy
Enrollment
422 pts
Location
United States
Sponsor
University of Vermont
View Trial →
NCT06734351 Phase 3
Recruiting
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adu...
Condition
Mid Face Volume Deficit
Enrollment
231 pts
Location
United States
Sponsor
AbbVie
View Trial →
NCT05786924 Phase 1, Phase 2
Recruiting
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Condition
Non-small Cell Lung Cancer
Enrollment
554 pts
Location
United States, Australia, China
Sponsor
Institut de Recherches Interna
View Trial →
NCT06828770 N/A
Recruiting
Minima Stent System Post- Approval Study (PAS)
Condition
Pulmonary Artery Stenosis
Enrollment
100 pts
Location
United States
Sponsor
Renata Medical
View Trial →
NCT05618054 N/A
Recruiting
Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural Histor...
Condition
Postural Tachycardia Syndrome
Enrollment
36 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
View Trial →
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07722546 Phase 2
Recruiting
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Sa...
Condition
Graves' Disease
Enrollment
60 pts
Location
United States, Puerto Rico
Sponsor
Biogen
View Trial →
NCT06136559 Phase 3
Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of I...
Condition
Chronic Lymphocytic Leukemia
Enrollment
1,200 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06445946 Phase 4
Recruiting
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Tr...
Condition
Gestational Diabetes Mellitus
Enrollment
1,572 pts
Location
United States
Sponsor
Ohio State University
View Trial →
NCT07357727 Phase 3
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Condition
Primary Myelofibrosis (PMF)
Enrollment
460 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07298941 Phase 2
Recruiting
Resilience Enhancement Following Sleep Treatment
Condition
Chronic Low Back Pain (CLBP)
Enrollment
300 pts
Location
United States
Sponsor
University of Virginia
View Trial →
NCT05426967 N/A
Recruiting
rTMS for Military TBI-related Depression
Condition
Depressive Symptoms
Enrollment
198 pts
Location
United States
Sponsor
Henry M. Jackson Foundation fo
View Trial →
NCT07684144 Phase 3
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of ...
Condition
Obesity
Enrollment
950 pts
Location
United States, Canada, Japan
Sponsor
Amgen
View Trial →
NCT05650632 Phase 1
Recruiting
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-3...
Condition
Multiple Myeloma
Enrollment
250 pts
Location
United States, Canada, Denmark
Sponsor
AbbVie
View Trial →
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT07160634 Phase 3
Recruiting
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrop...
Condition
Duchenne Muscular Dystrophy
Enrollment
80 pts
Location
United States, Australia, Canada
Sponsor
Solid Biosciences Inc.
View Trial →
NCT06175000 Phase 2
Recruiting
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lympho...
Condition
Primary Central Nervous System Lymphoma
Enrollment
28 pts
Location
United States
Sponsor
Providence Health & Services
View Trial →
Page 7 of 12 — 276 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology